Clinical Trials Browser

Phase 1/2 × Cytomegalovirus Infections × 1 year × Clear all

NCT06909110 2025-08-14

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Phase 1/2 Recruiting

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT06027879 2025-06-25

Gamma Capture

Phase 1/2 Enrolling by invitation

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT03475212 2025-05-11

ACES

Phase 1/2 Active not recruiting

Primary Immunodeficiency Diseases, Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections